AdaptHealth Corp. (AHCO)
NASDAQ: AHCO · Real-Time Price · USD
10.15
-0.35 (-3.33%)
At close: Nov 4, 2024, 4:00 PM
11.00
+0.85 (8.37%)
After-hours: Nov 4, 2024, 7:59 PM EST
AdaptHealth Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for AdaptHealth stock have an average target of 11.38, with a low estimate of 6.50 and a high estimate of 13. The average target predicts an increase of 12.12% from the current stock price of 10.15.
Analyst Consensus: Buy
* Price targets were last updated on Aug 12, 2024.
Analyst Ratings
The average analyst rating for AdaptHealth stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 2 | 2 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 0 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 5 | 5 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Reiterates $13 | Buy | Reiterates | $13 | +28.08% | Aug 12, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $13 | Strong Buy | Maintains | $13 | +28.08% | May 15, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $13 | Buy | Reiterates | $13 | +28.08% | Mar 4, 2024 |
| UBS | UBS | Strong Buy Maintains $9 → $13 | Strong Buy | Maintains | $9 → $13 | +28.08% | Feb 28, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $11 → $13 | Strong Buy | Maintains | $11 → $13 | +28.08% | Feb 28, 2024 |
Financial Forecast
Revenue This Year
3.34B
from 3.20B
Increased by 4.40%
Revenue Next Year
3.52B
from 3.34B
Increased by 5.21%
EPS This Year
0.61
from -5.31
EPS Next Year
1.02
from 0.61
Increased by 67.68%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 3.5B | 3.7B | 4.0B |
| Avg | 3.3B | 3.5B | 3.7B |
| Low | 3.2B | 3.3B | 3.5B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 8.0% | 9.8% | 13.9% |
| Avg | 4.4% | 5.2% | 6.5% |
| Low | -0.2% | -1.0% | -1.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 0.71 | 1.33 | 1.68 | ||
| Avg | 0.61 | 1.02 | 1.27 | ||
| Low | 0.50 | 0.77 | 0.77 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 120.1% | 65.4% | ||
| Avg | - | 67.7% | 25.1% | ||
| Low | - | 27.8% | -23.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.